Literature DB >> 1244454

MIRD/Dose Estimate Report No. 8. Summary of current radiation dose estimates to normal humans from 99mTc as sodium pertechnetate.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1244454

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  8 in total

1.  Results of regular study on radionuclidic purity of 99mTc obtained from 99Mo--99mTc generators.

Authors:  J Vlcek; V Husák; J Rohácek
Journal:  Eur J Nucl Med       Date:  1979-10

2.  Radiation doses to the eye lens from ocular tumour seeking radiopharmaceuticals.

Authors:  R Weinreich; H Bockslaff
Journal:  Eur J Nucl Med       Date:  1983

3.  Radiation absorbed dose estimates to the embryo from some nuclear medicine procedures.

Authors:  V Husák; M Wiedermann
Journal:  Eur J Nucl Med       Date:  1980-06

4.  Feasibility of adenovirus-mediated hNIS gene transfer and 131I radioiodine therapy as a definitive treatment for localized prostate cancer.

Authors:  Kenneth N Barton; Hans Stricker; Mohamed A Elshaikh; Jan Pegg; Jingfang Cheng; Yingshu Zhang; Kastytis C Karvelis; Mei Lu; Benjamin Movsas; Svend O Freytag
Journal:  Mol Ther       Date:  2011-05-17       Impact factor: 11.454

5.  In vivo labelling of RBC with 99mTc for blood pool imaging using different stannous radiopharmaceuticals.

Authors:  H I Popescu; J Lessem; M Erjavec; G F Füger
Journal:  Eur J Nucl Med       Date:  1984

6.  Radiation risk of thyroid scintigraphy in newborns.

Authors:  H Beekhuis; D A Piers
Journal:  Eur J Nucl Med       Date:  1983

7.  Diagnosis of deep vein thrombosis with in vivo 99mTc-labeled red blood cells.

Authors:  V Kempi; W van der Linden
Journal:  Eur J Nucl Med       Date:  1981-01

Review 8.  Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine - a review.

Authors:  Uta Eberlein; Jörn Hendrik Bröer; Charlot Vandevoorde; Paula Santos; Manuel Bardiès; Klaus Bacher; Dietmar Nosske; Michael Lassmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-30       Impact factor: 9.236
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.